» Articles » PMID: 28882103

Low Serum Vitamin D Levels in Type 2 Diabetes Patients Are Associated with Decreased Mycobacterial Activity

Overview
Journal BMC Infect Dis
Publisher Biomed Central
Date 2017 Sep 9
PMID 28882103
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Concurrent diabetes mellitus and tuberculosis represent a significant health problem worldwide. Patients with diabetes mellitus have a high risk of tuberculosis, which may be mediated by an abnormal innate immune response due to hyperglycaemia or low vitamin D levels.

Methods: In the present study, we evaluated inactive vitamin D serum levels and the monocyte response to infection with M. tuberculosis, including phagocytosis of M. tuberculosis, antimycobacterial activity, LL-37, human β defensin-2 and IL-10 gene expression and nitric oxide production, between type 2 diabetes mellitus patients (n = 51) and healthy volunteers (n = 38).

Results: Twenty-seven type 2 diabetes mellitus patients had inadequate inactive vitamin D levels (<50 nM). The percentages of M. tuberculosis phagocytosis between monocytes were similar across groups according to microscopy. Intracellular mycobacterial growth was similar in infected monocytes from both groups. However, M. tuberculosis growth was significantly higher in monocytes obtained from type 2 diabetes mellitus patients and lower vitamin D levels after 1-h (D0) and 72-h (D3) post-infection (p ≤ 0.05). LL-37, human β defensin-2 and IL-10 mRNA expression were similar between monocytes across groups; vitamin D serum levels and LL-37, human β defensin-2 and IL-10 expression were not correlated. Nitric oxide production was significantly higher in healthy volunteers than in type 2 diabetes mellitus patients with low vitamin D serum levels at D3 post-infection (p ≤ 0.05).

Conclusions: Our results show that monocytes from type 2 diabetes mellitus patients and low vitamin D serum levels show an impaired ability to control the intracellular growth of M. tuberculosis, which is not associated with significant decrease of LL-37 or human β defensin-2 expression. Vitamin D could be the link between diabetes and tuberculosis susceptibility.

Citing Articles

Differential Role of Type 2 Diabetes as a Risk Factor for Tuberculosis in the Elderly versus Younger Adults.

Restrepo B, Scordo J, Aguillon-Duran G, Ayala D, Quirino-Cerrillo A, Loera-Salazar R Pathogens. 2022; 11(12).

PMID: 36558885 PMC: 9784720. DOI: 10.3390/pathogens11121551.


High Vitamin D Concentrations Restore the Ability to Express LL37 by -Infected Human Macrophages.

Herrera M, Juarez E, Guzman-Beltran S, Torres M, Luna-Morales V, Villalana-Alvarez L Biomolecules. 2022; 12(2).

PMID: 35204769 PMC: 8961537. DOI: 10.3390/biom12020268.


Metformin partially reverses the inhibitory effect of co-culture with ER-/PR-/HER2+ breast cancer cells on biomarkers of monocyte antitumor activity.

Dahmani Z, Addou-Klouche L, Gizard F, Dahou S, Messaoud A, Chahinez Djebri N PLoS One. 2020; 15(10):e0240982.

PMID: 33108409 PMC: 7591052. DOI: 10.1371/journal.pone.0240982.


Type 2 Diabetes Mellitus and Altered Immune System Leading to Susceptibility to Pathogens, Especially .

Ferlita S, Yegiazaryan A, Noori N, Lal G, Nguyen T, To K J Clin Med. 2020; 8(12).

PMID: 31888124 PMC: 6947370. DOI: 10.3390/jcm8122219.


Changes in Host Response to Infection Associated With Type 2 Diabetes: Beyond Hyperglycemia.

Segura-Cerda C, Lopez-Romero W, Flores-Valdez M Front Cell Infect Microbiol. 2019; 9:342.

PMID: 31637222 PMC: 6787561. DOI: 10.3389/fcimb.2019.00342.


References
1.
Selvaraj P, Chandra G, Jawahar M, Rani M, Rajeshwari D, Narayanan P . Regulatory role of vitamin D receptor gene variants of Bsm I, Apa I, Taq I, and Fok I polymorphisms on macrophage phagocytosis and lymphoproliferative response to mycobacterium tuberculosis antigen in pulmonary tuberculosis. J Clin Immunol. 2004; 24(5):523-32. DOI: 10.1023/B:JOCI.0000040923.07879.31. View

2.
Takiishi T, Gysemans C, Bouillon R, Mathieu C . Vitamin D and diabetes. Endocrinol Metab Clin North Am. 2010; 39(2):419-46, table of contents. DOI: 10.1016/j.ecl.2010.02.013. View

3.
Zhang Y, Leung D, Richers B, Liu Y, Remigio L, Riches D . Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J Immunol. 2012; 188(5):2127-35. PMC: 3368346. DOI: 10.4049/jimmunol.1102412. View

4.
Liu P, Stenger S, Tang D, Modlin R . Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol. 2007; 179(4):2060-3. DOI: 10.4049/jimmunol.179.4.2060. View

5.
de Castro Kroner J, Sommer A, Fabri M . Vitamin D every day to keep the infection away?. Nutrients. 2015; 7(6):4170-88. PMC: 4488779. DOI: 10.3390/nu7064170. View